Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 14, 2026

May 14, 2026

Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes

Indeterminate GlobeNewswire

May 14, 2026

HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire

May 14, 2026

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

May 14, 2026

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May 14, 2026

BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire

May 14, 2026

Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May 14, 2026

Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

May 14, 2026

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

May 14, 2026

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

Indeterminate GlobeNewswire

May 14, 2026

Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments

Indeterminate GlobeNewswire

May 14, 2026

Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors

Indeterminate GlobeNewswire

May 14, 2026

SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

May 14, 2026

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

Indeterminate GlobeNewswire

May 14, 2026

Alumis Reports First Quarter 2026 Financial Results and Highlights Recent Achievements

Indeterminate GlobeNewswire

May 14, 2026

Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock

Indeterminate GlobeNewswire

May 14, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

May 14, 2026

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 14, 2026

Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 14, 2026

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

May 14, 2026

Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting

Indeterminate GlobeNewswire